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CC BY-NC-ND license (http://creativeAbstract In mammals, a thermogenic mechanism exists that increases heat production and
consumes energy. Recent work has shed light on the cellular and physiological mechanisms
that control this thermogenic circuit. Thermogenically active adipocytes, namely brown and
closely related beige adipocytes, differentiate from progenitor cells that commit to the ther-
mogenic lineage but can arise from different cellular origins. Thermogenic differentiation
shares some features with general adipogenesis, highlighting the critical role that common
transcription factors may play in progenitors with divergent fates. However, thermogenic dif-
ferentiation is also discrete from the common adipogenic program and, excitingly, cells with
distinct origins possess thermogenic competency that allows them to differentiate into ther-
mogenically active mature adipocytes. An understanding of this thermogenic differentiation
program and the factors that can activate it has led to the development of assays that are able
to measure thermogenic activity both indirectly and directly. By combining these assays with
appropriate cell models, novel therapeutic approaches to combat obesity and its related meta-
bolic disorders by enhancing the thermogenic circuit can be developed.
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Obesity and metabolic syndrome has reached worldwide
pandemic. According to the U.S. Center for Disease Control
and Prevention, two-thirds of the US population is over-
weight or obese. More than one-third of US adults and
approximately 17% of US children are obese. Worldwide,
more than 1 billion adults (15% of the world population) are
overweight and over 300 million people rank as truly obese.
Obesity and insulin resistance are two hallmark features for
a larger collection of metabolic syndromes. Indeed, in
addition to the 20 million people with type 2 diabetes, it is
estimated that over 40 million people in the U.S. have
metabolic syndrome, and it is this collection of abnormal-
ities which generates risk for many of our most common
medical disorders, including type 2 diabetes, dyslipidemia,
non-alcoholic fatty liver, cardiovascular disease, renal
failure, and even some cancers.1e4 The development of
prevention and treatment strategies for obesity and its co-
morbidities is of the utmost importance for the healthcare
and research communities. One appealing approach that
has garnered considerable interest over the last several
years is the investigation of the therapeutic potential of
brown adipose tissue (BAT).
BAT plays a pivotal role in thermogenesis, which is the
process by which energy is released in the form of heat to
maintain body temperature. In mice and humans, this
process can be mediated by the function of uncoupling
protein 1 (UCP1), which is expressed in the mitochondria of
brown and brown-like (also known as beige or brite) adi-
pocytes. Brown adipocytes are mostly located in the
interscapular region in rodents and constitutively express
UCP1 while beige adipocytes can be induced in white adi-
pose tissue upon cold or b-adrenergic stimulations.5 In adult
humans, UCP1-positive adipocytes are found in the neck,
supraclavicular and spinal cord regions.6e9
Simplifying the mechanism of UCP1 mediated
thermogenesis
UCP1 is a proton leak channel in the inner mitochondrial
membrane that uncouples the proton motive force gener-
ated by the electron transport chain (ETC) from ATP gen-
eration. UCP1 allows protons that are actively transported
across the semi-permeable membrane by the ETC to pass
back down their concentration gradient and bypass the V-
ATPase, releasing energy as heat rather than to activate
phosphorylation of ADP. One characteristic that distin-
guishes brown from beige adipocytes is that UCP1 expres-
sion is highly inducible by activators of thermogenic activity
in beige adipocytes, while UCP1 is constitutively expressed
at high levels in classical brown adipocytes.10e14
The molecular mechanism is easy to understand with
the simple metaphor of a car engine (Fig. 1). During
normal function, your car engine uses gasoline as an en-
ergy source to move the wheels forward, like cells use
glucose and fatty acids as energy sources for their mito-
chondria to produce ATP. When the gas pedal is depressed
and fuel is injected into the engine cylinder, an explosion
is triggered that combusts the gasoline and produces car-
bon dioxide and water. This gas is contained in thecylinder, producing energy to push up the engine piston
and propel the car forward and the cycle is then repeated.
In cells, the electron transport chain uses fuel like glucose
and fatty acids to pump protons into the inner mitochon-
drial membrane generating a proton motive force. During
normal oxidative phosphorylation, the energy in these
substrates would be used to “push” the ATPase enzyme
that generates ATP akin to the way the gasoline combus-
tion pushes the engine piston.15 The function of UCP1 can
be thought of as having the same effect as a small hole
drilled into the side of the engine cylinder in your car.
Instead of pushing up the piston and doing work for your
car, all of the gas and energy from combustion escapes
through the hole without pushing the piston. In cells,
thermogenesis occurs because the protons that might
provide energy for the ATPase are simply released by UCP1
back into the mitochondrial matrix, like gas escaping an
engine cylinder. It’s easy to imagine sitting in your
driveway, pressing the gas pedal and revving your car’s
engine, but going nowhere as you generate no force to
push the engine pistons and move your car forward.
Though you wouldn’t go anywhere as you revved your
engine and burned fuel, you would generate plenty of
heat, the same way brown and beige fat are able to burn
fuel and generate significant heat at the expense of ATP
production using UCP1 mediated proton leak.Activating a thermogenic mechanism
By activating the UCP1 mediated thermogenic mechanism,
BAT has been shown to regulate fatty acid metabolism and
glucose homeostasis.16e18 Given its influential role in the
regulation of nutrient metabolism, it is not surprising that
BAT mass/activity is inversely correlated to body mass
index and percent body fat in humans.19,20 Increasing the
size and activation of brown and beige adipose tissue has
the potential to alleviate the clinical sequelae of the
metabolic syndrome making recent clinical efforts to
demonstrate the feasibility of using cold regiments to
activate BAT in humans an exciting frontier.21e24
Therefore, brown and beige fat are the body’s main
tissues capable of activating a thermogenic circuit con-
sisting of adipocytes that metabolize substrates in order to
generate a proton motive force in mitochondria that is
subsequently uncoupled from ATP production to generate
heat. The steps of thermogenic differentiation can be co-
opted by distinct progenitor cell types that produce
mature cells with thermogenic capacity. Though they can
share certain aspects of a common adipogenic and ther-
mogenic differentiation program, cells at discrete stages
of differentiation express surface proteins and transcrip-
tional networks that are unique signatures of their specific
cellular lineage. The factors that promote the thermo-
genic circuit at each of its stages are of great therapeutic
interest in the field of obesity and diabetes and several
comprehensive reviews have thoroughly listed these
browning agents.14,25 In this review, in addition to updat-
ing the list of browning agents, we will define the stages of
cell differentiation and the inductive networks required to
complete full differentiation and activation of the ther-
mogenic circuit.
Figure 1 The basic principle of UCP1 mediated thermogenesis compared to a car engine. Your car engine normally combusts
gasoline to release CO2 and H2O inside of an enclosed engine cylinder. The gas released pushes up on a piston, sending its energy to
the wheels so you can drive forward. Similarly, mitochondria shuttle metabolites through the ETC to store protons on one side of
the inner mitochondrial membrane to generate an electrochemical gradient. The protons can pass down this gradient through an
ATPase, which uses the proton motive force as energy to phosphorylate ADP, generating ATP. Just as drilling a hole in the engine
cylinder would allow the gas produced by combustion to escape without pushing the piston, UCP1 is a channel that allows protons
to pass down their electrochemical gradient without activating ATP production. This energy from the proton motive force is instead
dissipated as heat, much like your car engine would heat up with holes drilled in the engine cylinders.
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Adipocytes are postmitotic and as a result hyperplasia of
adipose tissue requires proliferation and differentiation of
adipocyte precursor cells to form new mature adipocytes
both during development and throughout life.26,27 In mice,
BAT arises developmentally from cells in the dermomyo-
tome that express the transcription factors Pax728 and
myogenic factor 5 (Myf5).29,30 On the other hand, the ma-
jority of white adipocytes arise from cells lacking Myf5.31
During this process, multipotent progenitor cell pop-
ulations are triggered to commit to specific lineages by
induction cues in the stem cell niche. In adipose tissue, this
niche is located in the stromal vascular fraction (SVF) and
both human and mouse SVF contain cells that are capable
of differentiating into several different lineages.32 Experi-
ments carried out in mice have further revealed that SVF is
a mixture of uncommitted and committed adipose pro-
genitors.33,34 During adult life, adipocyte turnover may be
as frequent as 5% of mature cells per day requiring a large
reservoir of these progenitor cells.35 To meet this need,
committed preadipocytes are capable of significant
expansion before they become fully differentiated.33
Following commitment to the adipocyte lineage, dif-
ferentiation into mature adipocytes takes place and can beenhanced or inhibited by extrinsic cues. Some evidence
suggests that the action of extrinsic signals to promote
proliferation and differentiation of preadipocytes occurs in
a perivascular niche.36,37 In this model, cells that are
located close to vasculature receive inductive cues that
prompt their terminal differentiation and migration out of
the niche. Once fully mature, brown and beige adipocytes
are readily identifiable by their multilocular lipid droplets
and by expression of UCP1 protein, which is essential to
exert their thermogenic activity.Factors determining adipogenic and
thermogenic competency
During cell differentiation, certain stages of cell fate are
irreversible and represent a commitment to a given line-
age. Presumably, these stages correspond to distinct states
of heterochromatin that allow cells access to genes that
coordinately regulate cell identity. The primary stage is the
canonical differentiation cascade triggering the commit-
ment of mesenchymal progenitor cells to become the adi-
pose lineage, i.e., the preadipocytes (Fig. 2). Using lineage
tracing strategies, initial studies determined that only
brown adipocytes arise from a Myf5-positive lineage while
Figure 2 Thermogenic differentiation. Thermogenic mature adipocytes arise from both Myf5-positive and Myf5-negative lineages
that express a commitment gene program as they differentiate into committed precursor cells. This differentiation program has
both aspects common to brown, beige and white preadipocytes as well as aspects distinct to thermogenically competent pre-
adipocytes and can be enhanced by treatment with BMP7 or some members of the FGF family of proteins. Committed thermogenic
precursor cells can further differentiate into mature adipocytes by activating a gene network that also shares common features
with white adipogenesis, however, distinct thermogenic differentiation factors are also shared between brown and beige adipo-
cytes. This process can also be enhanced by a large group of diverse activators of thermogenic differentiation. Finally, mature
thermogenic adipocytes that express UCP1 can be further activated, yet distinct lineage specific markers that distinguish brown,
beige and white adipocytes exist.
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Myf5.30 Subsequent analysis has indicated that although a
small fraction of Myf5-positive cells are capable of under-
going white and beige adipogenesis, the majority of white
and beige adipocytes are derived from a Myf5-negative
lineage.31,38 Though there are some disagreements
regarding the exact contribution of the Myf5-positive and
Myf5-negative lineage to each pool of mature adipocytes,
the important concept is that Myf5 merely serves as a
lineage marker, both adipogenic differentiation and ther-
mogenic capacity are independent of expression of Myf5.
Mesenchymal progenitor cells differentiate into
committed adipocyte progenitors in response to inductive
signals such as bone morphogenetic proteins (BMPs), fibro-
blast growth factors (FGFs) and others that are expressed in
the niche to activate brown or beige differentiation.12
Several members of these developmental factor super-
family have been implicated in the regulation of brown fat
differentiation and functions as well as promoting browning
of white adipose tissues, including BMP7, 4, 8 and FGF16, 19
and 21.39e43 Presumably, these signals act through cell
surface receptors to activate signaling cascades thatregulate expression of key competency genes. Consistent
with an essential role of BMP7 in embryonic brown fat
development,44 deletion of the BMP receptor BMPR1a in
Myf5 expressing cells results in a paucity of interscapular
brown adipose tissue.45 BMP7 signaling via Smad proteins
suppresses expression of Pref-1, an EGF-repeat containing
protein which inhibits adipogenic differentiation.46 Zinc-
finger protein ZFP423 appears to be a determining factor
for a preadipocyte commitment via interacting with the
BMP-induced Smad protein and regulating peroxisome
proliferator-activated receptor gamma (PPARg) transcrip-
tion.36 Expression of ZFP423 is suppressed by another zinc-
finger protein ZFP521,47 highlighting that adipose commit-
ment is under a rigorous transcriptional regulation. Inter-
estingly, Pref-1 marks mesenchymal precursors at as early
as embryonic day 10.5, which is prior to the expression of
ZFP423 and PPARg.48
Cell sorting strategies have also led to a significant body
of knowledge describing the cell surface antigens that mark
cells committed to the adipose lineage. Notably, all pro-
genitor cells that are committed to the adipocyte lineage
express platelet derived growth factor receptor (PDGFR) a/
168 M.D. Lynes, Y.-H. Tsengb, CD34, CD29 and stem cell antigen 1 (Sca1).33,34,49 How-
ever, it remains unknown whether these proteins are
required to prime a cell for adipogenic differentiation or
they simply provide tools for isolation of committed adipose
progenitors.Transcriptional control of thermogenic fate
As surface markers that define progenitor cells that give
rise to brown, beige or white adipocytes remain to be
identified, efforts have been undertaken to identify tran-
scriptional regulators that mark committed preadipocytes.
The transcriptional regulator PRD1-BF1-RIZ1 homologous
domain containing 16 (PRDM16) controls a regulatory switch
in preadipocytes that is required for brown adipocyte dif-
ferentiation.30 Overexpression of PRDM16 in myogenic
precursors induces their differentiation into brown adipo-
cytes.30 Surprisingly, deletion of this factor in Myf5-
expressing progenitors has minimal effects on embryonic
brown fat development.50 Adipocyte-specific ablation of
PRDM16 has little impact on differentiation and function of
classical brown adipocytes, but results in impairment of
beige adipocyte formation in response to cold or
b3-adrenergic stimulation.51 Interestingly, activation of
PRDM16 is independent of the DNA binding domain of
PRDM16, implicating other potential transcription factors
that may act in concert with PRDM16 to promote or repress
transcription.52 Recently, the transcription factor early B
cell factor 2 (Ebf2) was shown to mark cells from both white
and brown adipose tissue that were committed to the
thermogenic fate.53,54 Ebf2 expression marks cells that
arise from both the Myf5-positive and Myf5-negative line-
age that give rise to brown and beige adipocytes, suggest-
ing that Ebf2 and its targets poise these cells to become
thermogenic competent after differentiation. Ebf2 is
thought to act as a co-regulator of gene expression with
PRDM16.
As previously mentioned, thermogenic competency may
also be a function of chromatin state maintained by a large
repertoire of histone modifying enzymes. In human em-
bryonic stem cells, PRDM16 has specific histone 3 lysine 9
(H3K9) methyltransferase activity. The H3K9 methylation
state is a critical determinant of gene activity and pre-
adipocytes that do not express PRDM16 may fail to properly
modify chromatin associated with the thermogenic differ-
entiation program.55,56 In addition to its own histone
modifying activity, PRDM16 associates other chromatin
modifying enzymes, including the proteins C-terminal-
binding-protein-1 (Ctbp1) and Ctbp2. These two proteins
are known to further recruit histone deacetylase enzymes
to modify chromatin.57,58 Moreover, the PRDM16 complex
also contains the protein euchromatic histone-lysine N-
methyltransferase 1 (EHMT1) which is required to suppress
myogenic differentiation of precursor cells by methylating
histones associated with muscle specific gene promoters to
suppress them.59
The mechanisms that link chromatin state, transcrip-
tional regulation and surface marker patterns and ulti-
mately determine adipose cell fate and thermogenic
potential are still being teased apart. Based on the current
understanding, cells from different lineages share commonprograms that allow them to fully access the adipogenic
and thermogenic gene networks required to differentiate
into white, beige or brown adipocytes.Factors regulating thermogenic differentiation
and activity
After commitment of precursor cells to an adipocyte line-
age, a second key step in the formation of mature adipo-
cytes relies on gene expression networks that complete
differentiation from competent cells. The transcriptional
regulators able to activate programs of terminal differen-
tiation have been extensively characterized and reviewed
elsewhere.33,60e65 Critically, terminal differentiation of
white preadipocytes shares a common fundamental tran-
scriptional program with brown and beige adipogenesis that
is dependent on expression of PPARg and the CCAAT/
enhancer-binding proteins (specifically C/EBPa/b/d).66,67
Downstream targets of these transacting regulatory fac-
tors are required for the formation of mature adipose tissue
in committed brown, beige and white adipocytes.
Similar to the commitment stage of differentiation, a
thermogenic differentiation program exists that is discrete
from the transcriptional machinery that promotes adipo-
genesis. It is known that the thermogenic circuit in brown
and beige fat can be activated by the sympathetic nervous
system in response to cold; however, other pathways and
circulating factors could also induce thermogenic activity
either by modulating the sympathetic input or through in-
dependent pathways. The canonical pathway regulating
BAT metabolic activity in response to cold relies on sym-
pathetic input resulting in the release of the catecholamine
neurotransmitter norepinephrine (NE) to activate G-protein
coupled adrenergic receptors and increase intracellular
cAMP. This process could be mimicked by pharmacological
compounds such as the b3-adrenergic receptor agonist CL
316,243. These stimuli enhance BAT thermogenic activity
and induce beige adipocyte formation in white adipose
tissue.68 The latter is mediated by increased differentiation
of precursor cells into thermogenically competent cells as
well as direct transdifferentiation.69 In addition to the ca-
nonical catecholamine pathway, several alternate path-
ways capable of increasing BAT thermogenic activity and/or
brown fat differentiation have been described.12,70 These
include classical hormones, such as thyroid hormone and
insulin, and newly identified endocrine factors, such as bile
acid, natriuretic peptides, FGF21, irisin and BMPs.
Recently, cellular tyrosine kinases in the Jak and Syk family
that negatively regulate thermogenic differentiation have
been identified.71 Thermogenic gene expression is driven by
PRDM16 and the transcriptional co-activator proliferator-
activated receptor gamma coactivator 1-alpha (PGC1a),
which activates mitochondrial biogenesis with mitochon-
drial transcription factor A (TFAM).72,73 In many respects,
this thermogenic program is again shared between brown
and beige adipocytes, however, it is clear that some dif-
ferences exist as these two cell types have distinct gene
expression profiles.6 During the later stages of differentia-
tion, the thermogenic program could be further enhanced
by both sympathetic dependent and independent
pathways.14,70
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Until recently, a lack of human brown adipocyte cell models
has prevented drug screening using human relevant cell
types. To meet this need, several groups have reported the
generation of cell lines that can be induced to become
brown/beige adipocytes.74,75 Perhaps the best cellular
system would be progenitors derived from bona fide human
brown adipose tissue as differentiated cells from these
progenitors serve as the standard for genuine human brown
adipocytes. These models present exciting opportunities to
screen for drugs that can enhance thermogenic compe-
tency and activity, however, careful assay design is
required in order to properly assess which effect any given
drugs has. Critical to this experimental design is the
treatment timeframe (Fig. 3A). As discussed above, lineage
commitment precedes differentiation. This means that
treatment paradigms that test compounds during the late
stages of differentiation require cells that have been
committed to the adipogenic lineage to gauge the full ef-
fect, whereas identification of reagents that promote the
commitment of progenitor cells to a thermogenic fate re-
quires treatment of uncommitted cells prior to adipogenic
induction.
Another opportunity for development lies in the assays
used to characterize the thermogenic circuit. In order to
increase activity of the thermogenic circuit, many influ-
encing factors that can be measured act on circuit com-
ponents. These factors are commonly measured by mRNA orFigure 3 Assaying the thermogenic circuit. (A) Adipogenic diff
phases: commitment, differentiation and maturity. Treatment with
appropriate treatment window. (B) The thermogenic circuit at the c
that generates a proton motive force, which can either be used to
activity of the cellular thermogenic circuit, influencing factors su
chondrial dynamics and UCP1 expression are often measured usingprotein expression, notably in the case of UCP1, the factor
directly upstream of heat production (Fig. 3B).
Measuring thermogenesis
As UCP1 is located in mitochondria, many assays also
determine metrics of mitochondrial dynamics. To deter-
mine mitochondrial mass, mitochondrial DNA copy number
is often measured using quantitative PCR. It is also possible
to assess mitochondrial mass histologically by electron
micrograph and several dyes are commercially available
that specifically stain mitochondria. Care should be taken
that staining intensity is representative of mitochondrial
mass as some dyes, specifically Mitotracker Red, are sen-
sitive to the mitochondrial membrane potential state. Po-
tential indicative of increased proton motive force may not
be associated with a browning effect, however, as UCP1
mediated uncoupling would actually decrease the mem-
brane potential even if metabolic flux were high. Tran-
scriptional regulators of mitochondrial biogenesis such as
TFAM and nuclear respirator factors 1 and 2 (NRF1 and
NRF2) can also be assessed. Finally components of the ETC
are often quantified by immunoblotting to measure the
capacity of mitochondria to generate the proton motive
force.
In order for mitochondria to generate the proton motive
force, fuel must be broken through many pathways that
serve to provide substrates to the ETC. Metabolic flux is
usually measured in a steady state or implied by theerentiation in vitro can be approximately divided into three
reagents that enhance each phase must be carried out in the
ellular level is composed of the metabolic flux through the cell
generate ATP or uncoupled to generate heat. To measure the
ch as substrate availability, metabolic enzyme activity, mito-
a broad range of different assays.
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rate limiting steps in the breakdown of fuel such as the
lipases adipose triglyceride lipase (ATGL), lipoprotein lipase
(LPL), hormone sensitive lipase (HSL) and carnitine palmi-
toyltransferase 1(Cpt1), which controls entry of fatty acids
into mitochondria. As thermogenic cells commonly use
glucose or fatty acids as fuel, uptake of these metabolites
can be measured. Along these lines, expression of key fatty
acid uptake proteins such as fatty acid transport proteins
1e4 (FATP1-FATP4) and CD36 can be measured. Recently,
high throughput image analysis of lipid droplet morphology
has also been used as a metric of substrate availability
based on the assumption that an increasing number of
smaller lipid droplets increases the surface area to volume
ratio and allows increased access to lipid molecules by
water soluble lipases in the cytoplasm to facilitate
metabolism.71
Currently, one limitation is that most of the assays used
to characterize thermogenesis, especially in vitro, do not
directly measure heat production. Thermal imaging at a
sub-cellular scale is possible, however, it requires nano-
particle injection into fixed cells and has yet to be adapted
to a high throughput methodology.76 It could be useful to
develop high throughput thermometry techniques assay the
thermogenic circuit by directly measuring heat production.
Another similar technological limitation exists when
determining the efficacy of potential thermogenic factors
in vivo. Most efforts to detect brown adipose tissue activity
and mass in humans rely on metabolite uptake to discrim-
inate thermogenically active tissue, however the need for
these techniques to be standardized has been recognized.77Therapeutic applications of the thermogenic
circuit
Gaining a better understanding of the thermogenic circuit
must ultimately be translated into therapeuticFigure 4 Therapeutic interventions to enhance the thermogenic
thermogenic circuit in man are possible. First, non cell-based thera
are possible. Second, cell-based therapies rely on adipose tissue
thermogenically competent preadipocytes ex vivo using either d
expanded and differentiated to produce large amounts of thermo
donor. Treatment of cells with activators of thermogenic compete
treatments on the rest of the body.applications, primarily to treat the metabolic syndrome.
The individual components of the thermogenic circuit make
a range of diverse therapeutic strategies possible (Fig. 4).
There are two main categories of therapies to activate
thermogenesis in humans. The first strategy relies on
treatments given directly to humans while the second
strategy is based on cell-based therapies.
Currently, treatments that directly activate the ther-
mogenic circuit in humans are quite diverse. Although cold
exposure is an effective way of activating brown adipose
tissue and several studies have demonstrated the clinical
feasibility of this approach,21,22,24 therapeutic cold expo-
sure is uncomfortable for humans. Diet and exercise based
interventions are also attractive given the pleiotropic
benefits of these strategies. In particular, foods that
contain capsaicin have been reported to activate brown
adipose tissue activity.78 Several drugs already clinically
available have been shown to activate brown adipose tis-
sue, such as the b-3 adrenergic agonist mirabegron.79 These
treatments are promising but side effects, particularly to
the cardiovascular system, may pose potential problems for
treatment of obese subjects.
Cell based therapies using autologous cell transfer to
activate the thermogenic circuit may provide another way
of potential treatment.80 After biopsy, cells can be cultured
and treated to enhance thermogenic competency or spe-
cific cell surface markers can be used for FACS sorting
strategies to enrich for thermogenically competent pro-
genitors. Once in culture, these cells can be expanded and
differentiated into thermogenically active adipocytes
before implantation back into the donor. One significant
advantage of this strategy is that cells can be treated with
compounds that enhance thermogenic competency and
differentiation in vitro, avoiding effects on other cell types
that might occur if humans were treated in vivo. Addi-
tionally, adipose stromal cells are highly proliferative and
could potentially serve as a large source of thermogenically
active adipocytes to combat obesity.circuit. Two different basic types of therapy for enhancing the
pies such as drugs, exercise, diet and therapeutic cold exposure
biopsy to provide SVF cells, which can be used to produce
rug treatment of cell sorting strategies. These cells can be
genic adipocytes for autologous transplantation back into the
ncy and differentiation ex vivo limits potential side effects of
Regulators of thermogenic competency and differentiation 171Understanding the thermogenic circuit is a key to
developing strategies to combat obesity and its sequelae.
Crucial to this is knowledge describing how thermogenically
active cells differentiate. By studying the process by which
cells commit to a thermogenically active fate experiments
can be designed that identify regulators at key steps of
thermogenic differentiation. The hope is that these regu-
lators can be translated into human therapy either by
activating the thermogenic circuit in vivo or by generating
cells ex vivo that can augment thermogenesis.
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